pet care
30% Pet Health EPS Surge For Elanco Vs Boehringer
Elanco’s cost-cutting measures drove a 30% rise in Q1 2026 earnings per share, outpacing Boehringer Ingelheim’s modest growth and shattering analysts’ forecasts. While the animal-health sector wrestles with supply-chain pressures, Elanco’s streamlined operations and pricing strategy delivered an earnings beat that resonated across Wall Street and pet-owner